cytidine has been researched along with zalcitabine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barchi, JJ; Driscoll, JS; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Shirasaka, T; Siddiqui, MA | 1 |
Borg, N; Ståhle, L | 1 |
Aubertin, AM; Bisagni, E; Dechaux, E; Dollé, V; Grierson, DS; Guillaumel, J; Legraverend, M; Monneret, C; Nguyen, CH; Note, R; Pontikis, R | 1 |
Gaubert, G; Gosselin, G; Maury, G; Salvatori, D; Vincenzetti, S; Vita, A | 1 |
Bacheler, L; Bazmi, H; Diamond, S; Erickson-Viitanen, S; Gallagher, K; Garber, S; Geleziunas, R; Hammond, J; Klabe, R; Liotta, DC; Manion, DJ; Mellors, J; Otto, MJ; Pierce, M; Rayner, M; Schinazi, RF; Stuyver, L; Trainor, G; Wu, JT; Zhang, H | 1 |
Gordon, YJ; Romanowski, EG | 1 |
Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M | 1 |
7 other study(ies) available for cytidine and zalcitabine
Article | Year |
---|---|
Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Chemical Phenomena; Chemistry, Physical; Cytarabine; Cytidine Deaminase; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Stability; HIV-1; Hydrogen-Ion Concentration; Macaca mulatta; Molecular Structure; Structure-Activity Relationship; Zalcitabine | 1992 |
Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis.
Topics: Animals; Anti-HIV Agents; Blood-Brain Barrier; Brain; Cytidine; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Zalcitabine | 1998 |
Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
Topics: Anti-HIV Agents; Cytidine; Enzyme Inhibitors; HIV Reverse Transcriptase; HIV-1; HIV-2; Molecular Structure; Pyridones; Structure-Activity Relationship; Uracil; Zalcitabine; Zidovudine | 2000 |
Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
Topics: Animals; Anti-HIV Agents; Cells, Cultured; Cytidine; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Sheep; Viral Load; Virus Replication; Visna-maedi virus; Zalcitabine | 2001 |
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants.
Topics: Animals; Anti-HIV Agents; Cytidine; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Macaca mulatta; Nucleosides; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 2002 |
Update on antiviral treatment of adenoviral ocular infections.
Topics: Adenoviridae Infections; Animals; Antiviral Agents; Cytidine; Eye Infections; Humans; Immunoglobulins, Intravenous; Zalcitabine | 2008 |
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine | 2012 |